We are excited to announce the opening and enrollment of patients across the US for our clinical study in newly diagnosed glioblastoma patients. Our current open sites can be found on clinicaltrials.gov. Learn more about our study at https://lnkd.in/d-QYVsWk #ClinicalStudy #Glioblastoma #PatientEnrollment #ResearchOpportunity #Healthcare #Innovation https://lnkd.in/dgZKvEKS
TVAX Biomedical, Inc.
生物技术研究
Lenexa，KS 403 位关注者
Vaccine-enhanced adoptive T cell immunotherapy ...developing an immune response against one's own tumor.
关于我们
TVAX Biomedical is a biotechnology company currently performing phase 2b/3 clinical trials to test a unique cancer immunotherapy as a treatment for pediatric brain cancer.
- 网站
-
https://tvaxbiomedical.com
TVAX Biomedical, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Lenexa，KS
- 类型
- 私人持股
- 领域
- Immunotherapy、Cancer、glioma、Pediatric glioma、T cell、T cell therapy、Cancer immunotherapy、Pediatric high grade glioma和Oncology
地点
-
获取路线
8006 Reeder Street
US，KS，Lenexa，66214